|
Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab
|
Dec 2014
|
Blood
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Are we ready to ring in a new upfront therapy in lower-risk myelodysplastic syndromes?
|
Jun 2023
|
Lancet
|
myelodysplastic syndromes (MDS)
|
|
Are we ready to ring in a new upfront therapy in lower-risk myelodysplastic syndromes?
|
Jul 2023
|
Lancet
|
myelodysplastic syndromes (MDS)
|
|
Are T-cell dysfunctions the other side of the moon in the pathogenesis of myelodysplastic syndromes?
|
Feb 2012
|
Eur J Haematol
|
myelodysplastic syndromes (MDS)
|
|
Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes?
|
Apr 2016
|
Haematologica
|
myelodysplastic syndromes (MDS)
|
|
Are Myelodysplastic Syndromes Underdiagnosed in Poland? A Report by the Polish Adult Leukaemia Group
|
Oct 2016
|
Eur J Haematol
|
myelodysplastic syndromes (MDS)
|
|
Are myelodysplastic syndromes and acute myeloid leukaemia occurring during the course of lymphoma always therapy related?
|
Sep 2016
|
Br J Haematol
|
myelodysplastic syndromes (MDS)
|
|
Application of the revised International Prognostic Scoring System for myelodysplastic syndromes in Argentinean patients
|
Jul 2013
|
Ann Hematol
|
myelodysplastic syndromes (MDS)
|
|
Application of the International Prognostic Scoring System-Revised (IPSS-R) in Therapy-related Myelodysplastic Syndromes and Oligoblastic Acute Myeloid Leukemia.
|
Jun 2013
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
Aplastic anemia: what have we learned from animal models and from the clinic.
|
Jun 2013
|
Semin Hematol
|
aplastic anemia
|
